期刊文献+

睡前中效胰岛素联合口服磺脲类降糖药治疗2型糖尿病的临床体会 被引量:3

Combination therapy with bedtime insuline and daytime oral hypoglycaernic in type2 diabetic patients
暂未订购
导出
摘要 目的观察睡前应用中效胰岛素联合口服磺脲类降糖药治疗2型糖尿病的临床效果。方法选择45例单用口服降糖药治疗失效的2型糖尿病患者,给予格列吡嗪及睡前加用中效胰岛素治疗,观察空腹血糖、餐后2 h血糖、糖化血红蛋白的变化及不良反应。结果睡前加用中效胰岛素治疗3个月后,FBG(空腹血糖)和2 h BG(餐后二小时血糖),HbAlc(糖化血红蛋白)水平均较治疗前显著降低(P均<0.01)。结论对单用口服降糖药效果欠佳的2型糖尿病,睡前加用中效胰岛素治疗效果显著。 Objective To observe the effects of the Combination therapy t with bedtime insuline and daytime oral bypoglycaernic in type2 diabetic patients. Methods 45 patients of type2 diabetic patients second- ery faliure to treatment with oral antidiabetic agents were treated by bedtime NPH insulin combined with OHAS for three months. Results The results show that there are significant decreases in FPG,2 hPG, HbAle com- pared to those in pre-medication( P 〈 0.01 ). None of hypoglyeemie cases occurred. Conclusion The Combination therapy t with bedtime insuline and daytime oral hypoglycaernicis are safe and effective in the treatment of patients with type 2 diabetes mellitus.
作者 荣佐民
出处 《中国实用医药》 2013年第8期45-46,共2页 China Practical Medicine
关键词 中效胰岛素 2型糖尿病 口服降糖药 NPH-insulin Type 2 diabetes Mellitus OHAS
  • 相关文献

参考文献3

二级参考文献36

  • 1Wright, A; Burden, AC; Paisey, - R - B; et al. Enadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U. K. Prospective Diabetes Study (UKPDS 57). Diabetes- Care 2002 Feb;25(2) :330 - 336.
  • 2Riddle, MC. Timely addition of insulin to oral therapy for type 2 diabetes. Diabetes- Care 2002 Feb;25(2): 395 - 396.
  • 3Scarpello, J H. Improving survival with metformin: the evidence base today. Diabetes- Metab 2003 Sep;29(4 Pt 2) :6536 - 6543.
  • 4Holman, RR; Cull, CA; Turner, RCA randomized double - blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U. K. Prospective Diabetes Study 44) Diabetes - Care 1999 Jun; 22(6): 960 - 964.
  • 5DeWitt, DE; Dugdale, DC. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. JAMA 2003May 7;289(17) :2265 - 2269
  • 6Furlong, NJ; Hulme, SA; O7 Brien, SV; et al. Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy.Diabetes- Care 2002 Oct;25(10): 1685 - 1690.
  • 7De- Jager, J; Kooy, A; Lehert, P; et al. Effects of short - term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebocontrolled trial. J - Intern- Med 2005 Jan;257(1): 100 - 109.
  • 8Kim JA, Kang WS, Lee SH, et al. Glibenclamtde induces apoptosis through inhibition of cystic fibrosis transmembrane conductans regulator(CFTR) CI^- channels and intracellular Ca^2+ release in HepG2 human hepatoblastoma cells. Biophys Biochem Res Commun 1999,261:682-688.
  • 9Ludvigsson J, Heding IG. Beta - cell function in children with diabetes. Diabetes 1977, 27(Suppl 1) : 230- 234.
  • 10Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104 (6) : 787 -794.

共引文献24

同被引文献16

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部